Microorganism causing urinary tract infection among children and their antimicrobial susceptibility patterns

Saeeda Nabat ul Hassan; Khushbu Farva; Ghulam Asghar Bhutta; Rabia Naseer Khan; Sadia Zia; Usman Ali

Abstract
Objective: To determine frequency of common bacteria causing urinary tract infection (UTI) among toilet-trained children and their antimicrobial susceptibility pattern.
Methodology: This descriptive cross sectional study was completed from October 2020 to March 2021 at pathology unit of Sahara Medical College, Narowal. It included 193 toilet-trained children with culture positive UTI. Demographic details like gender, age, residential area, and clinical findings along with isolated microorganism and antimicrobial sensitivity pattern were recorded. Mid-stream urinary samples were collected and sent to institutional laboratory for urine analysis, culture and antimicrobial sensitivity patterns.
Results: Out of 193 children, there were 108(54%) female and 91(47.2%) male. Mean age was 10.56±3.82 years (range 6-14). There were 107(55.4%) children above 10 years of age and 122(63.2%) belonged to rural areas. Most common bacteria isolated was E. coli in 155(80.3%) cases. Antimicrobials having highest sensitivity against the causative bacteria include imipenem and meropenem 189(97.9%), piperacillin tazobactam 187(96.9%), amikacin 185(95.8%), fosfomycin 184(95.3%), gentamycin 178(92.2%) and sulzone 171(88.6%).
Conclusion: E. Coli was the commonest bacteria causing UTI among toilet trained children. Antimicrobials with highest sensitivity against the causative organisms include imipenem, meropenem, piperacillin tazobactam, amikacin and fosfomycin.

Key words: Cutaneous infections, Staphylococcus aureus, Streptococcus pyogenes, Antibiotic susceptibility, Bacterial culture and sensitivity.

ABOUT JOURNAL About Publisher Contact Us Editorial & Peer Review Process	POLICIES Privacy Policy Editorial Policy Author's Rights and Obligations Conflict of Interest Policy Plagiarism Policy Advertising Policy	STATEMENTS Terms of Use Author's Rights and Obligations Publication Ethics and Publication Malpractice Statement Protection of Research Participants (Statement On Human And Animal Rights) License Information

This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author. This is in accordance with the Budapest Open Access Initiative (BOAI) definition of open access. The articles in Rawal Medical Journal are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc-sa/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.

Indexed in WHO Index Medicus IMEMR, Emromedex, Pakmedinet, ExtraMED, Scopus, Web of Science and Tehqeeqat

How to cite this article

	Open Access and Peer-reviewed
Home Journal Issues Guide for Authors Editorial Board Aims & Scope About Journal News & Announcements